Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. O.W. Akkerman

Speerpunten

Farmacokinetiek en farmacodynamiek van tuberculose medicijnen

Inhalatie van antimicrobiele medicatie

De holistische benadering van de behandeling van tuberculose

Publicaties

Aspergillus After Lung Transplantation: Prophylaxis, Risk Factors, and the Impact on Chronic Lung Allograft Dysfunction

Azithromycin as host-directed therapy for pulmonary tuberculosis - a randomized pilot trial

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

ERS Congress 2024: highlights from the Respiratory Infections Assembly

Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study

Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis

Pharmacokinetics of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor in Special Cystic Fibrosis Populations: A Systematic Review

Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and their active metabolites in plasma using UHPLC-MS/MS: Doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin in Children with Cystic Fibrosis

Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe

Pers/media

Margaretha (31) had tuberculose, maar geen arts die dat voor mogelijk hield

Geen bloedtest, maar zweettest bij onderzoek naar inname tbc-medicatie

Using Fingerprints to Detect Antibiotics

My congress 2024 video: Respiratory infections highlights

Aletta Talks. “Air pollution: out and inside”

Using a fingerprint for non-invasive drug monitoring

Scientists can now detect antibiotics in finger sweat